Trials / Conditions / Episodic Cluster Headache

Episodic Cluster Headache

9 registered clinical trials studyying Episodic Cluster Headache — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Ep NCT06882278	Beijing Tiantan Hospital	—
Unknown	Civamide Nasal Solution for Cluster Headache NCT01341548	Winston Laboratories	Phase 3
Terminated	A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster NCT02945046	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache NCT02797951	Eli Lilly and Company	Phase 3
Completed	A Study Of Galcanezumab In Participants With Episodic Cluster Headache NCT02397473	Eli Lilly and Company	Phase 3
Terminated	R-Verapamil for the Prophylaxis of Episodic Cluster Headache NCT02209155	Center Laboratories, Inc.	Phase 2
Unknown	Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache NCT00399243	Diamond Headache Clinic	Phase 4
Completed	Intranasal Civamide for Episodic Cluster Headache NCT00069082	Winston Laboratories	Phase 3
Completed	A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache NCT00033839	Winston Laboratories	Phase 3